These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37180718)

  • 1. Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy.
    Buijsers B; Garsen M; de Graaf M; Bakker-van Bebber M; Guo C; Li X; van der Vlag J
    Front Pharmacol; 2023; 14():1098184. PubMed ID: 37180718
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling.
    Kiyan Y; Tkachuk S; Kurselis K; Shushakova N; Stahl K; Dawodu D; Kiyan R; Chichkov B; Haller H
    Sci Rep; 2019 Sep; 9(1):13591. PubMed ID: 31537875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis.
    Buijsers B; Maciej-Hulme M; Jacobs M; Bebber MB; de Graaf M; Salmenov R; Parr N; Rabelink TJ; Nijenhuis T; van der Vlag J
    Front Mol Biosci; 2023; 10():1223972. PubMed ID: 37475889
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunohistochemical expression of heparanases 1 and 2 in benign tissue and in invasive neoplasia of the endometrium: a case-control study.
    Signorini Filho RC; de Azevedo Focchi GR; Theodoro TR; Pinhal MA; Nicolau SM
    Int J Gynecol Cancer; 2015 Feb; 25(2):269-78. PubMed ID: 25423319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hpa2 Gene Cloning.
    McKenzie E
    Adv Exp Med Biol; 2020; 1221():787-805. PubMed ID: 32274738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis.
    Garsen M; Benner M; Dijkman HB; van Kuppevelt TH; Li JP; Rabelink TJ; Vlodavsky I; Berden JH; Rops AL; Elkin M; van der Vlag J
    Am J Pathol; 2016 Apr; 186(4):805-15. PubMed ID: 26873445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase in Kidney Disease.
    van der Vlag J; Buijsers B
    Adv Exp Med Biol; 2020; 1221():647-667. PubMed ID: 32274730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based lead optimization to improve potency and selectivity of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid series of heparanase-1 inhibitor.
    Imai Y; Suzuki R; Wakasugi D; Matsuda D; Tanaka-Yamamoto N; Ohki Y; Mima M; Endo M; Tabata R; Matsuzawa H; Hasegawa Y; Kato S; Sugisaki M; Miyagawa H; Fujimoto N; Fukunaga T; Kato S; Takahashi T; Kakinuma H
    Bioorg Med Chem; 2023 Oct; 93():117460. PubMed ID: 37660465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid derivative as a potent and selective heparanase-1 inhibitor utilizing an improved synthetic approach.
    Imai Y; Suzuki R; Matsuda D; Tanaka-Yamamoto N; Ohki Y; Tabata R; Kato S; Sugisaki M; Fujimoto N; Fukunaga T; Kato S; Takahashi T; Kakinuma H
    Bioorg Med Chem Lett; 2024 Jan; 97():129543. PubMed ID: 37939863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy.
    Boels MGS; Koudijs A; Avramut MC; Sol WMPJ; Wang G; van Oeveren-Rietdijk AM; van Zonneveld AJ; de Boer HC; van der Vlag J; van Kooten C; Eulberg D; van den Berg BM; IJpelaar DHT; Rabelink TJ
    Am J Pathol; 2017 Nov; 187(11):2430-2440. PubMed ID: 28837800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lead identification of novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid derivative as a potent heparanase-1 inhibitor.
    Imai Y; Wakasugi D; Suzuki R; Kato S; Sugisaki M; Mima M; Miyagawa H; Endo M; Fujimoto N; Fukunaga T; Kato S; Kuroda S; Takahashi T; Kakinuma H
    Bioorg Med Chem Lett; 2023 Jan; 79():129050. PubMed ID: 36368497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy.
    Boels MG; Avramut MC; Koudijs A; Dane MJ; Lee DH; van der Vlag J; Koster AJ; van Zonneveld AJ; van Faassen E; Gröne HJ; van den Berg BM; Rabelink TJ
    Diabetes; 2016 Aug; 65(8):2429-39. PubMed ID: 27207530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetramethylpyrazine Alleviates Endothelial Glycocalyx Degradation and Promotes Glycocalyx Restoration via TLR4/NF-κB/HPSE1 Signaling Pathway During Inflammation.
    Lei J; Xiang P; Zeng S; Chen L; Zhang L; Yuan Z; Zhang J; Wang T; Yu R; Zhang W; Ibrahim II; Ma L; Yu C
    Front Pharmacol; 2021; 12():791841. PubMed ID: 35185540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria.
    Garsen M; Rops AL; Li J; van Beneden K; van den Branden C; Berden JH; Rabelink TJ; van der Vlag J
    PLoS One; 2016; 11(8):e0160894. PubMed ID: 27505185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte.
    Garsen M; Sonneveld R; Rops AL; Huntink S; van Kuppevelt TH; Rabelink TJ; Hoenderop JG; Berden JH; Nijenhuis T; van der Vlag J
    J Pathol; 2015 Dec; 237(4):472-81. PubMed ID: 26202309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx.
    Garsen M; Lenoir O; Rops AL; Dijkman HB; Willemsen B; van Kuppevelt TH; Rabelink TJ; Berden JH; Tharaux PL; van der Vlag J
    J Am Soc Nephrol; 2016 Dec; 27(12):3545-3551. PubMed ID: 27026367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparanase promotes radiation resistance of cervical cancer by upregulating hypoxia inducible factor 1.
    Li J; Meng X; Hu J; Zhang Y; Dang Y; Wei L; Shi M
    Am J Cancer Res; 2017; 7(2):234-244. PubMed ID: 28337373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.
    Wijnhoven TJ; van den Hoven MJ; Ding H; van Kuppevelt TH; van der Vlag J; Berden JH; Prinz RA; Lewis EJ; Schwartz M; Xu X
    Diabetologia; 2008 Feb; 51(2):372-82. PubMed ID: 18058084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of heparanase isoforms in intervertebral discs classified according to Pfirrmann grading system for disc degeneration.
    Rodrigues LM; Oliveira LZ; Pinhal MA
    Spine (Phila Pa 1976); 2013 Jun; 38(13):1112-8. PubMed ID: 23370684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-autonomous heparanase modulates self-renewal and migration in bone marrow-derived mesenchymal stem cells.
    Cheng CC; Lee YH; Lin SP; Huangfu WC; Liu IH
    J Biomed Sci; 2014 Mar; 21(1):21. PubMed ID: 24624965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.